Breaking News Instant updates and real-time market news.

ANET

Arista Networks

, CSCO

Cisco

$30.17

-0.17 (-0.56%)

09:16
10/14/16
10/14
09:16
10/14/16
09:16

Morgan Stanley positive on Arista, Cisco, cautious on F5 Networks, Juniper

Morgan Stanley analyst James Faucette favors Arista Networks (ANET), is positive on Cisco (CSCO) and cautious on F5 Networks (FFIV) and Juniper (JNPR) heading into Q3 results. The analyst expects another beat and raise for Arista and said increasing demand is straining availability but the company is prioritizing inventory to meet demand at hyperscales and the largest data center customers. Faucette expects Cisco to report in line results and said signs of stabilization in campus switch activity gives him confidence the strategy focus towards software and services will drive shares higher. He expects F5 to report an in line report with a modest improvement from new appliances ramp but is hearing crosscurrents on the longevity of the new product cycle. Finally, Faucette said Juniper's business continues to be below plan and is hearing instances of share loss in enterprise routers.

ANET

Arista Networks

CSCO

Cisco

$30.17

-0.17 (-0.56%)

FFIV

F5 Networks

$116.13

-1.67 (-1.42%)

JNPR

Juniper

  • 25

    Oct

  • 26

    Oct

  • 03

    Nov

  • 14

    Nov

  • 17

    Nov

  • 08

    Dec

  • 12

    Dec

  • 12

    Dec

ANET Arista Networks

08/18/16
JMPS
08/18/16
NO CHANGE
JMPS
Arista has positive read through from Cisco results, says JMP Securities
JMP Securities analyst Erik Suppiger says that Cisco's (CSCO) data center business grew 36% year-over-year, resulting in a positive read through for "vendors such as Arista (ANET). He keeps an $87 price target and Outperform rating on the latter stock.
08/18/16
BMOC
08/18/16
INITIATION
BMOC
Outperform
Arista Networks initiated at BMO Capital
As noted earlier, BMO Capital initiated coverage of Arista with an Outperform rating. Analyst Tim Long is upbeat on the company's fundamentals and expects it to gain share in data switching. Target $90.
09/14/16
DBAB
09/14/16
NO CHANGE
Target $85
DBAB
Buy
Arista Networks price target raised to $85 from $80 at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath raised his price target for Arista Networks to $85 after hosting the company as his firm's tech conference. The analyst has higher conviction in Arista's ability to meet or slightly beat consensus FY17/18 topline expectations due to solid near term demand trends at the Hyperscale Cloud customers. He keeps a Buy rating on the shares.
09/19/16
MKMP
09/19/16
DOWNGRADE
Target $79
MKMP
Neutral
Arista Networks downgraded to Neutral from Buy at MKM Partners
MKM Partners analyst Michael Genovese downgraded Arista Networks to Neutral and lowered its price target to $79 from $81. The analyst is concerned that the transition to all on-shore U.S. procurement and manufacturing could cause gross margins to come in lower than consensus, particularly in Q4 and 1H 2017.
CSCO Cisco
$30.17

-0.17 (-0.56%)

09/14/16
DBAB
09/14/16
NO CHANGE
Target $37
DBAB
Buy
Cisco price target raised to $37 from $35 at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath raised his price target for Cisco Systems to $37 from $35 after hosting the company at his firm's tech conference. The analyst sees "modestly improving demand trends" in cloud scale data center build outs and believes the company's October quarter guidance is de-risked. Bhagavath reiterates a Buy rating on Cisco.
09/19/16
IMPC
09/19/16
NO CHANGE
Target $190
IMPC
Outperform
Palo Alto win rates strong, can keep gaining share, says Imperial Capital
After meeting with Palo Alto Networks (PANW) management, Imperial Capital analyst Michael Kim noted that they highlighted their strong win rates when customers conduct head-to-head evaluations. Kim, who believes the company is gaining share in the network security market at the cost of Cisco (CSCO) and Check Point (CHKP), keeps an Outperform rating and $190 price target on Palo Alto shares.
09/23/16
OPCO
09/23/16
NO CHANGE
OPCO
Outperform
Speculation suggests Imperva takeover in 'near sight,' says Oppenheimer
Oppenheimer analyst Shaul Eyal is not surprised to see the list of potential Imperva (IMPV) buyer candidates mentioned in an article from Bloomberg, which includes Cisco (CSCO), IBM (IBM), Fortinet (FTNT), Akamai (AKAM), and privately held Forcepoint. The analyst envisions Imperva's product line aligning particularly well with Cisco's and IBM's given the recent drive by both to expand their security offerings. Eyal sees a potential price target ranging between $55-$60 if the speculation has any merit and sufficient interest from multiple bidders. Oppenheimer has an Outperform rating on Imperva's shares.
10/10/16
UBSW
10/10/16
NO CHANGE
Target $35
UBSW
Buy
Consensus may be underestimating Cisco security growth, says UBS
UBS analyst Steven Milunovich said Cisco needs to grow its security business by double digits for the stock to outperform. He believes the company can do that and sees the Street underestimating its ability in security, citing the company's opportunity to leverage its network dominance and differentiate by providing a unified offering versus competitors' piecemeal parts. Milunovich reiterated his Buy rating and $35 price target on Cisco shares.
FFIV F5 Networks
$116.13

-1.67 (-1.42%)

07/21/16
COWN
07/21/16
NO CHANGE
Target $141
COWN
Outperform
F5 Networks price target raised to $141 from $125 at Cowen
Cowen raised its price target on F5 Networks to $141 from $125 following its solid beat and raise Q3 results. The firm sees a ramp of new product introductions and upgrades, ongoing margin expansion, and a ramp in software-based revenue. Cowen reiterated its Outperform rating on F5 Networks shares.
08/31/16
OTRG
08/31/16
NO CHANGE
OTRG
F5 Networks standalone security applicance launch delayed, says OTR Global
OTR Global's checks indicate F5 Networks' much anticipated standalone security appliances launch has been delayed until October at the earliest.
09/14/16
OPCO
09/14/16
UPGRADE
Target $140
OPCO
Outperform
F5 Networks upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Ittai Kidron upgraded F5 Networks to Outperform with a $140 price target after hosting investor meetings with management. The company has several potential drivers that could drive year-over-year product revenue growth back into positive territory in FY17, Kidron tells investors in a research note. The analyst sees upside to the shares.
09/14/16
09/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Macy's (M) upgraded to Buy from Neutral at Citi with analyst Paul Lejuez saying an attractive free cash flow and dividend yield makes the risk/reward attractive at current levels. 2. Fifth Third (FITB) upgraded to Buy from Neutral at Compass Point. 3. F5 Networks (FFIV) upgraded to Outperform from Perform at Oppenheimer with analyst Ittai Kidron saying the company has several potential drivers that could drive year-over-year product revenue growth back into positive territory in fiscal 2017. 4. Las Vegas Sands (LVS) upgraded to Buy from Hold at Argus with analyst John Staszak saying that Macau gambling is shifting towards the non-VIP market, where he believes that Las Vegas Sands is well-positioned. 5. DeVry (DV) upgraded to Outperform from Market Perform at Barrington with analyst Alexander Paris saying management's near-term goal is stabilizing revenue at DeVry University growing enrollment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JNPR Juniper

06/22/16
JMPS
06/22/16
NO CHANGE
JMPS
Activist investor could persuade Imperva to sell itself, says JMP Securities
After activist investor Elliott acquired a 10% stake in Imperva (IMPV), JMP Securities thinks that Elliott will persuade the company to consider strategic alternatives and could convince the company to look to sell itself.. The firm believes that the company is "a strong acquisition prospect" for large companies such as HP (HPE), Cisco (CSCO), Juniper (JNPR), and Symantec (SYMC). The firm believes that Elliott will improve the company's cost management and execution. It reiterates a $57 price target and Outperform rating on Imperva.
07/01/16
OTRG
07/01/16
NO CHANGE
OTRG
Juniper's Q2 enterprise business stabilized, says OTR Global
OTR Global said Juniper's enterprise business stabilized during Q2, following the SAP implementation in January, and sales plan and win rate trends slightly quarter-over-quarter despite concerns about backlog.
07/06/16
DBAB
07/06/16
DOWNGRADE
Target $22
DBAB
Hold
Juniper downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath downgraded Juniper Networks to Hold saying his firm's Service Provider Channel research indicated the potential for margin pressure and share loss in the company's Routing business in FY17 and FY18. The analyst cut his price target for Juniper shares to $22 from $30.
07/20/16
PIPR
07/20/16
NO CHANGE
PIPR
Piper survey shows networking infrastructure demand slowed meaningfully
Piper Jaffray analyst Troy Jensen says his firm's Q2 Networking survey, which consisted of 36 resellers/distributors located in the U.S. and Europe, indicated that demand for networking infrastructure saw a meaningful slowdown in the June quarter. The survey indicated demand was weak across most vendors, with "some of the worst results in recent memory" from Cisco (CSCO), Juniper (JNPR) and F5 Networks (FFIV), Jensen tells investors in a research note. The analyst recommends caution on the space heading into the Q2 earnings season.

TODAY'S FREE FLY STORIES

GS

Goldman Sachs

$249.02

1.67 (0.68%)

, TAL

TAL Education

$85.58

0.33 (0.39%)

13:51
02/27/17
02/27
13:51
02/27/17
13:51
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs, TAL Education »

Goldman Sachs reports…

GS

Goldman Sachs

$249.02

1.67 (0.68%)

TAL

TAL Education

$85.58

0.33 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 03

    Mar

MYGN

Myriad Genetics

$18.98

-0.07 (-0.37%)

, VCYT

Veracyte

$7.95

0.06 (0.76%)

13:50
02/27/17
02/27
13:50
02/27/17
13:50
Recommendations
Myriad Genetics, Veracyte analyst commentary  »

Piper sees CMS halt of…

MYGN

Myriad Genetics

$18.98

-0.07 (-0.37%)

VCYT

Veracyte

$7.95

0.06 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

13:50
02/27/17
02/27
13:50
02/27/17
13:50
General news
Treasury Action: yield have spiked higher as rate hike fears flare up »

Treasury Action: yield…

LJPC

La Jolla

$19.87

1.65 (9.06%)

13:39
02/27/17
02/27
13:39
02/27/17
13:39
Recommendations
La Jolla price target raised to $40 from $27 at Jefferies »

Jefferies analyst Eun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 19

    Mar

NH

NantHealth

$7.54

-0.08 (-1.05%)

, MDRX

Allscripts

$12.05

-0.11 (-0.90%)

13:33
02/27/17
02/27
13:33
02/27/17
13:33
Hot Stocks
CTCA partners with Allscripts, NantHealth to launch Clinical Pathways »

Cancer Treatment Centers…

NH

NantHealth

$7.54

-0.08 (-1.05%)

MDRX

Allscripts

$12.05

-0.11 (-0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

VRAY

ViewRay

$4.76

0.01 (0.21%)

13:30
02/27/17
02/27
13:30
02/27/17
13:30
Recommendations
ViewRay analyst commentary  »

ViewRay price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 06

    Mar

AIG

AIG

$63.97

0.34 (0.53%)

13:29
02/27/17
02/27
13:29
02/27/17
13:29
Periodicals
AIG board to discuss whether to penalize or oust CEO over Q4 numbers, WSJ says »

AIG's directors are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

HAIN

Hain Celestial

$34.61

-0.23 (-0.66%)

13:26
02/27/17
02/27
13:26
02/27/17
13:26
Options
Hain Celestial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$82.00

3.7 (4.73%)

13:19
02/27/17
02/27
13:19
02/27/17
13:19
Downgrade
bluebird bio rating change  »

Follow-up: bluebird bio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

$NSD

NASDAQ Market Internals

13:17
02/27/17
02/27
13:17
02/27/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
02/27/17
02/27
13:16
02/27/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$82.00

3.7 (4.73%)

13:15
02/27/17
02/27
13:15
02/27/17
13:15
Downgrade
bluebird bio rating change  »

bluebird bio downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

STM

STMicroelectronics

$15.49

0.485 (3.23%)

13:06
02/27/17
02/27
13:06
02/27/17
13:06
Options
STMicroelectronics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$81.47

0.385 (0.47%)

13:05
02/27/17
02/27
13:05
02/27/17
13:05
Periodicals
Exxon CEO sees rising Permian production, continued Russia presence, Forbes says »

Speaking in a Forbes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

SAFM

Sanderson Farms

$94.44

-0.72 (-0.76%)

13:01
02/27/17
02/27
13:01
02/27/17
13:01
Conference/Events
Sanderson Farms management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

DDAIF

Daimler AG

$72.92

-0.39 (-0.53%)

13:01
02/27/17
02/27
13:01
02/27/17
13:01
Hot Stocks
Daimler names Martin Daum head of Trucks, Buses divisions »

Daimler said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$186.67

-0.7399 (-0.39%)

13:00
02/27/17
02/27
13:00
02/27/17
13:00
Hot Stocks
IPTAB upholds validity of 3M Korean patent »

The Intellectual Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

trivago

$12.85

-0.13 (-1.00%)

12:57
02/27/17
02/27
12:57
02/27/17
12:57
Conference/Events
trivago management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

SSNLF

Samsung

, FB

Facebook

$135.44

0.08 (0.06%)

12:55
02/27/17
02/27
12:55
02/27/17
12:55
Hot Stocks
Samsung says new Facebook app available for Samsung TVs »

Samsung (SSNLF) announced…

SSNLF

Samsung

FB

Facebook

$135.44

0.08 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 28

    Mar

SNAP

Snap Inc.

12:52
02/27/17
02/27
12:52
02/27/17
12:52
Hot Stocks
Snap Inc: Some Class A shares subject to separate lock-up »

In an amended IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

MRVL

Marvell

12:51
02/27/17
02/27
12:51
02/27/17
12:51
Options
Notable premium seller in Marvell Tech »

Notable premium seller in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 10

    Mar

  • 04

    Apr

  • 05

    Apr

WLL

Whiting Petroleum

$10.95

0.15 (1.39%)

12:46
02/27/17
02/27
12:46
02/27/17
12:46
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

CLSD

Clearside Biomedical

$8.06

1.16 (16.81%)

12:45
02/27/17
02/27
12:45
02/27/17
12:45
Conference/Events
Clearside Biomedical has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

SBGSY

Schneider Electric

$13.49

-0.21 (-1.53%)

12:44
02/27/17
02/27
12:44
02/27/17
12:44
Conference/Events
Schneider Electric management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 02

    Mar

  • 03

    Mar

MTB

M&T Bank

$168.14

-0.535 (-0.32%)

12:37
02/27/17
02/27
12:37
02/27/17
12:37
Hot Stocks
M&T Bank announces passing of COO Mark Czarnecki »

M&T Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.